Cargando…

Chidamide and Radiotherapy Synergistically Induce Cell Apoptosis and Suppress Tumor Growth and Cancer Stemness by Regulating the MiR-375-EIF4G3 Axis in Lung Squamous Cell Carcinomas

As a selective histone deacetylase (HDAC) inhibitor developed in China, chidamide has been applied for the treatment of refractory peripheral T-cell lymphoma (PTCL) and multiple solid tumors, including lung cancer. However, the underlying mechanisms are not well elucidated. In our present study, we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Xu, Bi, Nan, Wang, Jingbo, Ren, Hua, Pan, Desi, Lu, Xianping, Wang, Luhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214506/ https://www.ncbi.nlm.nih.gov/pubmed/34194495 http://dx.doi.org/10.1155/2021/4936207

Ejemplares similares

miR-375 and miR-205 Regulate the Invasion and Migration of Laryngeal Squamous Cell Carcinoma Synergistically via AKT-Mediated EMT
por: Wang, Bin, et al.
Publicado: (2016)

Chidamide and apatinib are therapeutically synergistic in acute myeloid leukemia stem and progenitor cells
por: Zhao, Haijun, et al.
Publicado: (2022)

MiR‐375/SLC7A11 axis regulates oral squamous cell carcinoma proliferation and invasion
por: Wu, Yadong, et al.
Publicado: (2017)

The Synergistic Antitumor Activity of Chidamide in Combination with Bortezomib on Gastric Cancer
por: Zhang, Wanjun, et al.
Publicado: (2020)

Synergistic effect of chidamide and venetoclax on apoptosis in acute myeloid leukemia cells and its mechanism
por: Li, Gangping, et al.
Publicado: (2021)

Chidamide and Oxaliplatin Synergistically Inhibit Colorectal Cancer Growth by Regulating the RPS27A-MDM2-P53 Axis
por: Li, Zhaopeng, et al.
Publicado: (2023)

LUCAT1 as an oncogene in tongue squamous cell carcinoma by targeting miR‐375 expression
por: Zhang, Kai, et al.
Publicado: (2021)

Chidamide in the treatment of peripheral T-cell lymphoma
por: Chan, Thomas S, et al.
Publicado: (2017)

A miR-375/YAP axis regulates neuroendocrine differentiation and tumorigenesis in lung carcinoid cells
por: Yang, Xiaojing, et al.
Publicado: (2021)

Chidamide and venetoclax synergistically exert cytotoxicity on multiple myeloma by upregulating BIM expression
por: Cao, Liqin, et al.
Publicado: (2022)

lncRNA UASR1 is overexpressed in oral squamous cell carcinoma and regulates cancer cell proliferation by regulating miR-375/JAK2 axis
por: Sun, Yugang, et al.
Publicado: (2021)

miR-375 suppresses the growth and metastasis of esophageal squamous cell carcinoma by targeting PRDX1
por: Wu, Kunpeng, et al.
Publicado: (2022)

Chidamide and decitabine can synergistically induce apoptosis of Hodgkin lymphoma cells by up-regulating the expression of PU.1 and KLF4
por: Jiang, Tao, et al.
Publicado: (2017)

Synergistic effect of HDAC inhibitor Chidamide with Cladribine on cell cycle arrest and apoptosis by targeting HDAC2/c-Myc/RCC1 axis in acute myeloid leukemia
por: Gu, Siyu, et al.
Publicado: (2023)

miR-375 Suppresses IGF1R Expression and Contributes to Inhibition of Cell Progression in Laryngeal Squamous Cell Carcinoma
por: Luo, Jie, et al.
Publicado: (2014)

Synergistic activation of eIF4A by eIF4B and eIF4G
por: Nielsen, Klaus H., et al.
Publicado: (2011)

Chidamide Reverses Fluzoparib Resistance in Triple-Negative Breast Cancer Cells
por: Li, Xinyang, et al.
Publicado: (2022)

Correction: Chidamide and decitabine can synergistically induce apoptosis of Hodgkin lymphoma cells by up-regulating the expression of PU.1 and KLF4
por: Jiang, Tao, et al.
Publicado: (2018)

Cell-Specific Detection of miR-375 Downregulation for Predicting the Prognosis of Esophageal Squamous Cell Carcinoma by miRNA In Situ Hybridization
por: Li, Jiangchao, et al.
Publicado: (2013)

Effect of chidamide on treating hepatosplenic T-cell lymphoma: A case report
por: Wang, Xing-Tong, et al.
Publicado: (2020)

Restoration of miR-23a expression by chidamide sensitizes CML cells to imatinib treatment with concomitant downregulation of CRYAB
por: Zhu, Xunxun, et al.
Publicado: (2022)

Upregulation of CD22 by Chidamide promotes CAR T cells functionality
por: Yang, Xin, et al.
Publicado: (2021)

Long noncoding RNA MLK7-AS1 promotes ovarian cancer cells progression by modulating miR-375/YAP1 axis
por: Yan, Huan, et al.
Publicado: (2018)

PB1753: SYNERGISTIC ANTITUMOR EFFECT OF CHIDAMIDE WITH VENETOCLAX IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA BY SUPPRESSING PI3K/AKT SIGNALING
por: Song, D., et al.
Publicado: (2022)

lncRNA TINCR Regulates Proliferation and Invasion of Hepatocellular Carcinoma Cells by Regulating the miR-375/ATG7 Axis
por: Tang, Chengwu, et al.
Publicado: (2022)

A novel circ_0000654/miR‐375/E2F3 ceRNA network in esophageal squamous cell carcinoma
por: Luo, Chunyu, et al.
Publicado: (2022)

Synergistic Apoptosis-Inducing Effects on A375 Human Melanoma Cells of Natural Borneol and Curcumin
por: Chen, Jianping, et al.
Publicado: (2014)

The ASH1-miR-375-YWHAZ Signaling Axis Regulates Tumor Properties in Hepatocellular Carcinoma
por: Zhao, Juan-Feng, et al.
Publicado: (2018)

Multimechanism Synergistic Photodetectors with Ultrabroad Spectrum Response from 375 nm to 10 µm
por: Wang, Xudong, et al.
Publicado: (2019)

Remission of pulmonary alveolar proteinosis after radiotherapy in a patient with comorbid small cell lung cancer
por: Xiang, Yongbo, et al.
Publicado: (2023)

Combination of betulinic acid and chidamide synergistically inhibits Epstein-Barr virus replication through over-generation of reactive oxygen species
por: Yu, Haibing, et al.
Publicado: (2017)

Dual regulation of miR-375 and CREM genes in pancreatic beta cells
por: Keller, David M., et al.
Publicado: (2022)

Potential involvement of miR-375 in the premalignant progression of oral squamous cell carcinoma mediated via transcription factor KLF5
por: Shi, Wen, et al.
Publicado: (2015)

miR-375-3p inhibits the progression of laryngeal squamous cell carcinoma by targeting hepatocyte nuclear factor-1β
por: Chang, Kunpeng, et al.
Publicado: (2020)

Hsa_circ_0129047 regulates the miR‐375/ACVRL1 axis to attenuate the progression of lung adenocarcinoma
por: Fan, Jinxiu, et al.
Publicado: (2022)

Circ-SNX27 sponging miR-375/RPN1 axis contributes to hepatocellular carcinoma progression
por: Zheng, Chao, et al.
Publicado: (2023)

Retraction Note: Long noncoding RNA MLK7-AS1 promotes ovarian cancer cells progression by modulating miR-375/YAP1 axis
por: Yan, Huan, et al.
Publicado: (2020)

miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis
por: Kang, Wei, et al.
Publicado: (2018)

Comparison of Chemotherapy Combined With Chidamide Versus Chemotherapy in the Frontline Treatment for Peripheral T-Cell Lymphoma
por: Wang, Jinni, et al.
Publicado: (2022)

CircASPH promotes KGN cells proliferation through miR‐375/MAP2K6 axis in Polycystic Ovary Syndrome
por: Wu, Gengxiang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_es3pk7kn9o5hfpc7sg47cn2bin